Scion Capital fund manager Michael Burry's top 5 holdings

On Tuesday, Feb. 16, the SEC released filings from many high-profile investors, one of which includes Michael Burry. Dr. Michael J. Burry is a well-known investor and hedge fund manager of Scion Asset Management, LLC Holdings. Below are Burry's top 5 holdings by dollar amount according to the most recent filing:

No 5: NOW Inc. (NYSE: DNOW)

$10,770,000

NOW Inc is an energy company located in Houston, Texas.  Michael Burry is betting big on energy stocks in 2021. He initiated a position in downstream energy product provider NOW Inc. during the fourth quarter by purchasing shares worth more than $10.77 million. It is the fifth-largest stock holding of Scion Asset Management, representing 4.79% of the overall portfolio. Shares of NOW soared close to 50% since the beginning of this year, thanks to improving commodity prices.

No. 4: Lumen Technologies(NYSE: LUMN) $11,213,000

Lumen Technologies Inc, the parent company of CenturyLink, offers communication technology such as WiFi and cloud services. Michael Burry is bullish on the fundamentals of Lumen Technologies. He has increased his stake in Lumen by 43% in the fourth quarter, making it the fourth-largest stock holding of the 13F portfolio. Shares of the facilities-based communications company grew 24% since the beginning of this year. Also, the company offers more than an 8% dividend yield to shareholders. 

No 3: Kraft Heinz Co., (NASDAQ: KHC)

 $20,439,000 

Kraft Heinz Company is a staple consumer goods company in the United States, producing hundreds of household products. Burry bought $204,390 in call options on Kraft Heinz Co that could be worth more than $20 million if executed.

KHC share price has extended the upside momentum into 2021 amid strong financial numbers. The company has generated December quarter revenue of around $6.94B, up 6.1% from the year-ago period, with expectations for similar growth in the upcoming quarters.

No. 2: Pfizer (NYSE: PFE)

$31,079,000

The New-York based drugmaker, Pfizer raised its earnings outlook for 2021. It now expects to report earnings in the range of $3.10 per share to $3.20 per share for the current fiscal year, as compared to its previous guidance between $3.00 per share to $3.10 per share.  This outlook comes as the company expects to generate $15 billion in revenue from its COVID-19 vaccine. 

Burry purchased more than $300,000 in Pfizer Inc. call options and is hoping that it proves to be the most effective out of the bunch. Pfizer plans to make 2 billion doses of the vaccine this year.

No. 1:CitiGroup (NYSE: C)

$33,272,000

In what might be a surprise to some investors, Burry’s biggest position in the most recent filing was Citigroup Inc. Burry bought more than $330,000 in call options on the investment firm. CitiGroup’s stock hasn’t moved much throughout the last six months, but Burry is betting it will with these $33 million in call options.